Axogen (AXGN) Current Deferred Tax Assets (2010 - 2011)

Axogen (AXGN) posted quarterly Current Deferred Tax Assets of $18000.0 for Q2 2011, down 96.65% quarter-over-quarter from $538000.0 in Q4 2010.

Axogen (AXGN) Current Deferred Tax Assets (2010 - 2011) Analysis & Trends

Axogen's Current Deferred Tax Assets history runs 2 years deep, the most recent figure standing at $18000.0 for Q2 2011.

In Q2 2011, Current Deferred Tax Assets changed N/A year-over-year to $18000.0; the TTM figure through Jun 2011 stood at $18000.0 (changed N/A YoY), while the FY2010 annual figure was $538000.0, changed N/A from the prior year.
Current Deferred Tax Assets for Q2 2011 stood at $18000.0, down from $538000.0 in the prior quarter.
The five-year high for Current Deferred Tax Assets was $538000.0 in Q4 2010, with the low at $18000.0 in Q2 2011.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	202.72 Bn	197.12 Bn	7.27 Bn
2	Stryker	126.42 Bn	122.94 Bn	4.50 Bn
3	Medtronic	119.75 Bn	110.53 Bn	6.41 Bn
4	Boston Scientific	74.13 Bn	73.60 Bn	3.85 Bn
5	Edwards Lifesciences	51.78 Bn	47.53 Bn	1.35 Bn
6	Dexcom	35.29 Bn	33.34 Bn	830.00 Mn
7	GE HealthCare Technologies	33.95 Bn	31.85 Bn	2.18 Bn
8	Koninklijke Philips	26.22 Bn	22.90 Bn	4.55 Bn
9	Steris	23.21 Bn	22.73 Bn	684.20 Mn
10	Axogen	2.69 Bn	2.58 Bn	50.67 Mn

Download Data